Although the IL-2/IL-2R signaling pathway is thought to be blocked by CTLA-4 [16], the serum level of sIL-2R was not correlated with that of sCTLA-4 in our patients with CCRCC. The gene discussed is IL2; the disease is nonpapillary renal cell carcinoma.